Works in European Journal of Immunology, 2002, Vol 32, Issue 10


Results: 36
    1
    2
    3
    4
    5
    6
    7
    8

    Anouncements.

    Published in:
    European Journal of Immunology, 2002, v. 32, n. 10, p. 3027, doi. 10.1002/1521-4141(2002010)32:10<3027::AID-IMMU3027>3.0.CO;2-5
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Contribution of CD8.

    Published in:
    European Journal of Immunology, 2002, v. 32, n. 10, p. 2807, doi. 10.1002/1521-4141(2002010)32:10<2807::AID-IMMU2807>3.0.CO;2-0
    By:
    • Berg, Rance E.;
    • Cordes, Christoph J.;
    • Forman, James
    Publication type:
    Article
    21
    22
    23

    NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.

    Published in:
    European Journal of Immunology, 2002, v. 32, n. 10, p. 2711, doi. 10.1002/1521-4141(2002010)32:10<2711::AID-IMMU2711>3.0.CO;2-3
    By:
    • Sirianni, Maria Caterina;
    • Vincenzi, Laura;
    • Topino, Simone;
    • Giovannetti, Antonello;
    • Mazzetta, Francesca;
    • Libi, Fabio;
    • Scaramuzzi, Donato;
    • Andreoni, Massimo;
    • Pinter, Elena;
    • Baccarini, Sara;
    • Rezza, Giovanni;
    • Monini, Paolo;
    • Ensoli, Barbara
    Publication type:
    Article
    24
    25
    26
    27
    28

    The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.

    Published in:
    European Journal of Immunology, 2002, v. 32, n. 10, p. 2857, doi. 10.1002/1521-4141(2002010)32:10<2857::AID-IMMU2857>3.0.CO;2-R
    By:
    • Rharbaoui, Faiza;
    • Drabner, Birgit;
    • Borsutzky, Stefan;
    • Winckler, Urte;
    • Morr, Michael;
    • Ensoli, Barbara;
    • Mühlradt, Peter F.;
    • Guzmán, Carlos A.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36